查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722930

血漿衍生物市場規模、佔有率、趨勢及預測（按類型、應用、最終用戶和地區），2025 年至 2033 年

Blood Plasma Derivatives Market Size, Share, Trends and Forecast by Type, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球血漿衍生物市場規模價值為 482.7 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 759 億美元，2025 年至 2033 年的複合年成長率為 5.2%。北美目前佔據市場主導地位，到 2024 年市佔率將超過 48.9%。慢性病盛行率的上升、先進的血漿採集基礎設施、技術創新、老年人口的成長以及治療應用的擴大是推動該地區市場成長的一些因素。

血漿衍生物是透過分餾過程從血漿中獲得的特定蛋白質的濃縮物。因子 VIII、免疫球蛋白、白蛋白、超免疫球蛋白、因子 IX 和新鮮冷凍血漿是一些常見的血漿衍生物。它們富含蛋白質、礦物質、鹽、荷爾蒙、維生素和蛋白酶抑制劑，因此被廣泛用於殺滅導致B型肝炎、甲型血友病、出血性疾病、免疫缺陷、丙型肝炎、低丙種球蛋白血症、乙型血友病和人類免疫缺陷病毒（HIV）的病毒。此外，血漿衍生物有助於增強營養、控制體溫和血液凝固、維持滲透壓、增強呼吸和排泄、調節酸鹼平衡。血漿衍生物通常儲存在醫院、診所、診斷中心和輸血中心。

血漿衍生物市場趨勢：

老年人口的不斷增加更容易患上傳染病，這為市場帶來了積極的前景。血漿中含有免疫球蛋白，在免疫系統的形成中起著重要作用，並維持血管內的滲透壓，從而進一步預防免疫缺陷病和血友病的發病。此外，透過恢復期血漿療法治療冠狀病毒病 (COVID-19) 患者的產品廣泛採用有利於市場成長。此外，分餾過程中的各種技術創新有助於分離蛋白質濃縮物和血漿中的各種成分以用於臨床目的，為市場成長提供了相當大的推動力。與此相符的是，先進保存方法的發展以及用於開發有針對性的治療產品的封裝程序的顯著改進進一步促進了市場的成長。其他因素，包括醫療保健行業的顯著成長、人們對血液和血漿捐贈的認知不斷提高以及政府為推廣捐血活動而實施的各種舉措，預計將推動市場進一步成長。

本報告回答的關鍵問題

  • 什麼是血漿衍生物？血漿衍生性商品市場有多大？
  • 2025 年至 2033 年期間全球血漿衍生物市場的預期成長率為何？
  • 推動全球血漿衍生物市場發展的關鍵因素有哪些？
  • 根據類型，全球血漿衍生物市場的主要部分是什麼？
  • 根據應用，全球血漿衍生物市場的主要部分是什麼？
  • 根據最終用戶來看，全球血漿衍生物市場的主要細分市場是什麼？
  • 全球血漿衍生物市場的主要區域有哪些？
  • 全球血漿衍生物市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球血漿衍生物市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：依類型

  • 白蛋白
  • 第八因子
  • 凝血因子IX
  • 免疫球蛋白
  • 高免疫球蛋白
  • 其他

第7章：市場區隔：依應用

  • 血友病
  • 低丙種球蛋白血症
  • 免疫缺乏疾病
  • 血管性血友病
  • 其他

第8章：市場區隔：按最終用戶

  • 醫院
  • 診所
  • 其他

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Baxter International Inc.
    • Bayer AG
    • CSL Limited
    • Fusion Health Care Pvt. Ltd.
    • Grifols SA
    • Kedrion SpA
    • LFB SA
    • Octapharma AG
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
Product Code: SR112025A5371

The global blood plasma derivatives market size was valued at USD 48.27 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 75.9 Billion by 2033, exhibiting a CAGR of 5.2% from 2025-2033. North America currently dominates the market, holding a market share of over 48.9% in 2024. The rising chronic disease prevalence, advanced plasma collection infrastructure, technological innovations, growing geriatric population, and expanding therapeutic applications are some of the factors driving the market growth in this region.

Blood plasma derivatives are concentrates of specific proteins prepared from plasma that are obtained through fractionation process. Factor VIII, immunoglobulin, albumin, hyperimmune globulin, factor IX and fresh frozen are some of the common blood plasma derivatives. They are rich in proteins, minerals, salts, hormones, vitamins and protease inhibitors, due to which they are widely used to kill viruses that cause hepatitis B, hemophilia A, bleeding disorders, immunodeficiency, hepatitis C, hypogammaglobulinemia, hemophilia B and human immunodeficiency virus (HIV). Apart from this, blood plasma derivatives assist in enhancing nutrition, controlling body temperature and coagulation of blood, maintaining osmotic pressure, enhancing respiration and excretion, and regulating acid-base balance. Blood plasma derivatives are commonly stored at hospitals, clinics, diagnostic centers and blood transfusion centers.

Blood Plasma Derivatives Market Trends:

The increasing geriatric population that are more susceptible to developing infectious diseases are creating a positive outlook for the market. Blood plasma contains immunoglobulins that play an important role in the development of immunity and maintain the osmotic pressure in blood vessels, which further prevents the onset immunodeficiency disorders and hemophilia. Moreover, the widespread product adoption to treat coronavirus disease (COVID-19) patients by convalescent plasma treatment is favoring the market growth. Additionally, various technological innovations in the fractionation process that aids in separating protein concentrates and various components of blood plasma for clinical purposes are providing a considerable boost to the market growth. In line with this, the development of advanced preservation methods, along with the significant improvements in encased procedures for developing targeted therapeutic products are further augmenting the market growth. Other factors, including significant growth in the healthcare industry, increasing awareness regarding blood and plasma donation and the implementation of various government initiatives to promote blood donation camps, are anticipated to drive the market further toward growth.

Key Market Segmentation:

Breakup by Type:

  • Albumin
  • Factor VIII
  • Factor IX
  • Immunoglobulin
  • Hyperimmune Globulin
  • Others

Breakup by Application:

  • Hemophilia
  • Hypogammaglobulinemia
  • Immunodeficiency Diseases
  • Von Willebrand's Disease
  • Others

Breakup by End User:

  • Hospitals
  • Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Bayer AG, CSL Limited, Fusion Health Care Pvt. Ltd., Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, Sanofi S.A. and Takeda Pharmaceutical Company Limited.

Key Questions Answered in This Report

  • 1.What are blood plasma derivatives?
  • 2.How big is the blood plasma derivatives market?
  • 3.What is the expected growth rate of the global blood plasma derivatives market during 2025-2033?
  • 4.What are the key factors driving the global blood plasma derivatives market?
  • 5.What is the leading segment of the global blood plasma derivatives market based on type?
  • 6.What is the leading segment of the global blood plasma derivatives market based on application?
  • 7.What is the leading segment of the global blood plasma derivatives market based on end user?
  • 8.What are the key regions in the global blood plasma derivatives market?
  • 9.Who are the key players/companies in the global blood plasma derivatives market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Plasma Derivatives Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Albumin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Factor VIII
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Factor IX
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Immunoglobulin
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Hyperimmune Globulin
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Hemophilia
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Hypogammaglobulinemia
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunodeficiency Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Von Willebrand's Disease
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Clinics
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Bayer AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 CSL Limited
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Fusion Health Care Pvt. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Grifols S.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Kedrion S.p.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 LFB S.A.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Octapharma AG
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takeda Pharmaceutical Company Limited
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Blood Plasma Derivatives Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Plasma Derivatives Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Blood Plasma Derivatives Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Blood Plasma Derivatives Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Blood Plasma Derivatives Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Blood Plasma Derivatives Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Blood Plasma Derivatives Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Blood Plasma Derivatives (Albumin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Blood Plasma Derivatives (Albumin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Blood Plasma Derivatives (Factor VIII) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Blood Plasma Derivatives (Factor VIII) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Blood Plasma Derivatives (Factor IX) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Blood Plasma Derivatives (Factor IX) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Blood Plasma Derivatives (Immunoglobulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Blood Plasma Derivatives (Immunoglobulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Blood Plasma Derivatives (Hyperimmune Globulin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Blood Plasma Derivatives (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Blood Plasma Derivatives (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Blood Plasma Derivatives (Hemophilia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Blood Plasma Derivatives (Hemophilia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Blood Plasma Derivatives (Hypogammaglobulinemia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Blood Plasma Derivatives (Immunodeficiency Diseases) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Blood Plasma Derivatives (Von Willebrand's Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Blood Plasma Derivatives (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Blood Plasma Derivatives (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Blood Plasma Derivatives (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Blood Plasma Derivatives (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Blood Plasma Derivatives (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Blood Plasma Derivatives (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Global: Blood Plasma Derivatives (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Global: Blood Plasma Derivatives (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: North America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: North America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: United States: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: United States: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Canada: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Canada: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Asia-Pacific: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Asia-Pacific: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: China: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: China: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Japan: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Japan: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: India: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: India: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: South Korea: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: South Korea: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Australia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Australia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Indonesia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Indonesia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Europe: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Europe: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Germany: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Germany: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: France: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: France: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: United Kingdom: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: United Kingdom: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Italy: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Italy: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Spain: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Spain: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Russia: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Russia: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Latin America: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Latin America: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Brazil: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Brazil: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Mexico: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Mexico: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Others: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Others: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Middle East and Africa: Blood Plasma Derivatives Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 83: Middle East and Africa: Blood Plasma Derivatives Market: Breakup by Country (in %), 2024
  • Figure 84: Middle East and Africa: Blood Plasma Derivatives Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Global: Blood Plasma Derivatives Industry: SWOT Analysis
  • Figure 86: Global: Blood Plasma Derivatives Industry: Value Chain Analysis
  • Figure 87: Global: Blood Plasma Derivatives Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Plasma Derivatives Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Blood Plasma Derivatives Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Blood Plasma Derivatives Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Blood Plasma Derivatives Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Blood Plasma Derivatives Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Blood Plasma Derivatives Market: Competitive Structure
  • Table 7: Global: Blood Plasma Derivatives Market: Key Players